WHO RSV Roadshow Web Event 1

On Tuesday 3rd of September we organised in collaboration with WHO and PATH the first Web Event “On the Verge of RSV Disease Prevention: A Primer.

Why focus on RSV, and why now? Join this expert-hosted discussion on the importance of preventing RSV–the world’s top cause of severe respiratory infections and hospitalisations in infants and young children–and the newly licensed immunisation products that offer an unprecedented chance to address it. This overview will cover RSV disease, its burden, prevention products and considerations for programmatic use to protect infants in low- and middle-income markets.

Recording Available

Catch up on our recent web event, ‘On the Verge of RSV Disease Prevention: A Primer’. Watch the full recording below to gain valuable insights from leading experts in the field.

Presentation slides

Thank you to our host and speakers

Prof. Heather Zar

(Red Cross Children’s Hospital & University of Cape Town– South Africa)

As a global expert in childhood respiratory diseases, Heather Zar has built a strong clinical translational research program focused on key childhood illnesses in Africa and globally, including pneumonia, RSV and developmental origins of health. She participates in several trials of new RSV preventive strategies in children. She is past-President of the Forum of International Respiratory Societies, of the Pan African Thoracic Society, and has served as an advisor to WHO, UNICEF and the Gates Foundation.

Dr. Daniel Feikin

(Initiative for Vaccine Research- Immunizations, Vaccines & Biologicals, World Health Organization (WHO) – Geneva, Switzerland)

Daniel Feikin received his medical degree at Harvard University, did his residency in Internal Medicine at University of California San Francisco, and received his MSPH at University of Colorado. He completed the Epidemic Intelligence Program at the US Centers for Disease Control and Prevention, and continued to work for CDC for 20 years, mostly focused on bacterial and viral causes of respiratory illness.

Dr. Senjuti Saha

Director & Senior Scientist, Child Health Research Foundation, Bangladesh

Senjuti Saha is a molecular microbiologist and an activist based in Bangladesh, working at the intersection of clinical microbiology and global health. She completed her PhD in Molecular Genetics at the University of Toronto in Canada, and received post-doctoral training at the Hospital for Sick Children, Canada and Stanford University, USA.

Upcoming Events

Web Events Program 2024 – 2025

If you have registered for the first WHO RSV Roadshow, you don’t need to register again. You will receive a email with an invitation to a Teams meeting and register only with your name and email address.